Sign Up Today and Learn More About Noema Pharma Stock
Invest in or calculate the value of your shares in Noema Pharma or other pre-IPO companies through EquityZen's platform.
Noema Pharma Stock (NOPH)
Noema Pharma is a biotech company that develops therapies to address disabling symptoms in conditions of the brain and nervous system.
About Noema Pharma Stock
Founded
2019
Industries
Science and Engineering, Health Care, Biotechnology
Noema Pharma Press Mentions
Stay in the know about the latest news on Noema Pharma
Use of triple uptake inhibitor for the treatment of atypical depression
patents • Apr 02, 2025
Use of a phosphodiesterase 10 inhibitor for the treatment of tourette syndrome
patents • Apr 02, 2025
Noema Pharma extends Series B funding to CHF 130 million
startupticker • Mar 10, 2025
Trigeminal Neuralgia Market Set to Grow Substantially Through 2032, DelveInsight Projects
einpresswire • Feb 10, 2025
Methods of treatment of dravet syndrome
patents • Feb 07, 2025
Noema Pharma Management
Leadership team at Noema Pharma
Co-Founder and CEO
Luigi Costa
CMO & Co-Founder
George Garibaldi
Join now and verify your accreditation status to gain access to:
- Noema Pharma Current Valuation
- Noema Pharma Stock Price
- Noema Pharma Management
- Available deals in Noema Pharma and all other companies with relevant Deal Offering documents
- EquityZen's proprietary data and insights, which may include
- Noema Pharma Cap Table and Funding History by Share Class and Liquidity Preferences
- Noema Pharma Revenue and Financials
- Noema Pharma Highlights
- Noema Pharma Business Model
- Noema Pharma Risk Factors
- Noema Pharma Research Report from SACRA Research
Trading Noema Pharma Stock
How to invest in Noema Pharma stock?
Accredited investors can buy pre-IPO stock in companies like Noema Pharma through EquityZen funds. These investments are made available by existing Noema Pharma shareholders who sell their shares on our platform. Typically, these are early employees who need to fund a life event – house, education, etc. Accredited investors are then offered the opportunity to invest in this stock through a fund, like those used by hedge funds serving large investors. While not without risk, investing in private companies can help investors reach goals of portfolio diversification, access to potential growth and high potential return. Learn more about our Guided Investment process here.
How to sell Noema Pharma stock?
Shareholders can sell their Noema Pharma stock through EquityZen's private company marketplace. EquityZen's network includes over 360K accredited investors interested in buying private company stock. Learn more about the easy and guided Shareholder process here.
If I invest, how do I exit my investment?
There are two ways to exit your private company investment on EquityZen's marketplace. The first is if the company has an exit event like an IPO, merger or acquisition. In that case, we will distribute the shares and/or cash to you directly. The second way is through an Express Deal on EquityZen, if eligible. An Express Deal allows you to sell your allocation of private shares in a given private company to another investor on EquityZen's marketplace. More information on Express Deals can be found here and exit information can be found here.
Why choose EquityZen?
Since 2013, the EquityZen marketplace has made it easy to buy and sell shares in private companies. EquityZen brings together investors and shareholders, providing liquidity to early shareholders and private market access to accredited investors. With low investment minimums through our funds and with more than 46K private placements completed across 450+ companies, EquityZen leads the way in delivering "Private Markets for the Public."
